Diabetes and Ramadan: Practical guidelines.
Mohamed Hassanein,Monira Al-Arouj,Osama Hamdy,Wan Mohamad Wan Bebakar,Abdul Jabbar,Abdulrazzaq Al-Madani,Wasim Hanif,Nader Lessan,Abdul Basit,Khaled Tayeb,Mak Omar,Khalifa Abdallah,Abdulaziz Al Twaim,Mehmet Akif Buyukbese,Adel Abdel Aziz El-Sayed,Abdullah Bennakhi +15 more
Reads0
Chats0
TLDR
The IDF-DAR Practical Guidelines should enhance knowledge surrounding the issue of diabetes and Ramadan fasting, thereby empowering healthcare professionals to give the most up-to-date advice and the best possible support to their patients during Ramadan.About:
This article is published in Diabetes Research and Clinical Practice.The article was published on 2017-04-01 and is currently open access. It has received 247 citations till now.read more
Citations
More filters
Journal ArticleDOI
Original paper: Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30: A phase 3, multicentre, international, open-label, randomised, treat-to-target trial in patients with type 2 diabetes fasting during Ramadan.
Mohamed Hassanein,Akram Echtay,Rachid Malek,M. A K Omar,Shehla Shaikh,Magnus Ekelund,Kadriye Kaplan,Nor Azmi Kamaruddin +7 more
TL;DR: IDegAsp is a suitable therapeutic agent for patients who need insulin for sustained glucose control before, during and after Ramadan fasting, with a significantly lower risk of hypoglycaemia, versus BIAsp 30, an existing premixed insulin analogue.
Journal ArticleDOI
Diabetes and Ramadan: A multicenter study in Algerian population.
TL;DR: Diabetic patients insist on fasting regardless of their doctors' warnings, and the main consequences were hyperglycemia and hypoglycemia.
Journal ArticleDOI
The role of optimum diabetes care in form of Ramadan focused diabetes education, flash glucose monitoring system and pre-Ramadan dose adjustments in the safety of Ramadan fasting in high risk patients with diabetes.
Mohamed Hassanein,Elamin Abdelgadir,Alaaeldin Bashier,Fauzia Rashid,Maryam Al Saeed,A. A. Khalifa,Fawzi Eltayb,Sona Abuelkheir,Mohammed Abdellatif,Fatima Sayyah,Suad Khalifa,Fatheya Alawadi +11 more
TL;DR: The value of optimum care in diabetes management during Ramadan on the metabolic parameters of high risk patients with diabetes, as well as the safety of fasting in this group, is assessed.
Journal ArticleDOI
Assessment of Ramadan Education and Knowledge Among Diabetic Patients
Mussa H. Almalki,Ibtihal Hussen,Shawana Abdulhamid Khan,Abdulrahman Almaghamsi,Fahad Alshahrani +4 more
TL;DR: Ramadan health education in diabetes can encourage, improve, and guide patients to change their lifestyles during Ramadan while minimizing the risk of acute complications.
Journal ArticleDOI
Diabetes Canada Position Statement for People With Types 1 and 2 Diabetes Who Fast During Ramadan.
Harpreet S. Bajaj,Tyceer Abouhassan,Muhammad Rauf Ahsan,Amel Arnaout,Amel Arnaout,Mohamed Hassanein,Mohamed Hassanein,Robyn L. Houlden,Tayyab Khan,Hasnain Khandwala,Subodh Verma +10 more
TL;DR: This is the first Canadian position statement on the topic of Ramadan fasting and diabetes, developed by an expert faculty and endorsed by Diabetes Canada, and provides guidance about pharmacotherapy and glucose monitoring for health-care providers so that they can assist Canadian Muslims living with diabetes to observe fasting during Ramadan safely.
References
More filters
Journal ArticleDOI
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
TL;DR: Clinical trials with the incretin mimetic exenatide and liraglutide show reductions in fasting and postprandial glucose concentrations, and haemoglobin A1c (HbA1c) associated with weight loss, but long-term clinical studies are needed to determine the benefits of targeting the inc retin axis for the treatment of type 2 diabetes.
Journal ArticleDOI
Impact of sleep debt on metabolic and endocrine function
TL;DR: Sleep debt has a harmful impact on carbohydrate metabolism and endocrine function similar to those seen in normal ageing and, therefore, sleep debt may increase the severity of age-related chronic disorders.
Journal ArticleDOI
Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.
TL;DR: Careful postmarketing surveillance for adverse effects, especially among the DPP4 inhibitors, and continued evaluation in longer-term studies and in clinical practice are required to determine the role of this new class of pharmacotherapies for type 2 diabetes.
Journal ArticleDOI
A Population-Based Study of Diabetes and Its Characteristics During the Fasting Month of Ramadan in 13 Countries Results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) study
Ibrahim Salti,Eric Bénard,Bruno Detournay,Monique Bianchi-Biscay,Corinne Le Brigand,Céline Voinet,Abdul Jabbar +6 more
TL;DR: There is a need to provide more intensive education before fasting, to disseminate guidelines, and to propose further studies assessing the impact of fasting on morbidity and mortality.
Journal ArticleDOI
Adiponectin: action, regulation and association to insulin sensitivity
TL;DR: Adiponectin in addition to possible anti‐inflammatory and anti‐atherogenic effects appears to be an insulin enhancer, with potential as a new pharmacologic treatment modality of the metabolic syndrome and type 2 diabetes.